Type
Offshoring/Delocalisation
Country
Austria
Region
Westösterreich; Oberösterreich; Linz-Wels
Location of affected unit(s)
Linz
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
New offshoring locations

85 - 100 jobs
Number of planned job losses
Job loss
Announcement Date
12 March 2008
Employment effect (start)
12 March 2008
Foreseen end date

Description

In January 2008, Nycomed Austria, a subsidiary of the Danish pharmaceutical company Nycomed, announced its plans to relocate some of the activities currently performed at its main site in Linz (Upper Austria) to a joint venture company in India. According to a company spokesperson, 85 jobs (other sources allege 100 jobs) are to be cut at the Linz site in the next three or four years. The restructuring is necessary to remain competitive, he stated, since nearly all chemical enterprises based in industrialised countries have started moving their pharmaceutical production to ‘low-wage countries’, which necessarily entails declining market prices. The Linz plant currently employs a workforce of around 550 workers. The workers affected will be covered by a social plan.


Sources

  • 26 January 2008: Oberösterreichische Nachrichten
  • 12 March 2008: Der Standard

Citation

Eurofound (2008), Nycomed Austria, Offshoring/Delocalisation in Austria, factsheet number 66440, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66440.